Green C, Lakshmipathi T
Department of Dermatology, Ninewells Hospital, Dundee, Scotland.
Dermatologica. 1991;182(2):119-20. doi: 10.1159/000247758.
The case of a 41-year-old male patient is described who developed acute reversible hepatitis related to etretinate therapy. During the course of etretinate he received 2 doses of hepatitis B vaccine; this and his HLA typing A1, A2, Bw57, Cw6 may have predisposed him to develop this reaction.
本文描述了一名41岁男性患者的病例，该患者因维甲酸治疗出现急性可逆性肝炎。在服用维甲酸期间，他接种了2剂乙肝疫苗；这以及他的HLA分型A1、A2、Bw57、Cw6可能使他易发生这种反应。
